MAL2 interacts with IQGAP1 to promote pancreatic cancer progression by increasing ERK1/2 phosphorylation

被引：19
|
作者：
Zhang, Bin [1 ,2 ]
Xiao, Jun [1 ,2 ]
Cheng, Xiang [1 ,2 ]
Liu, Tao [1 ,2 ]
机构：
[1] Huazhong Univ Sci & Technol, Union Hosp, Dept Digest Surg Oncol, Tongji Med Coll, Wuhan 430022, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430022, Peoples R China
来源：
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2021年 / 554卷
基金：
中国国家自然科学基金;
关键词：
MAL2; IQGAP1; ERK; Pancreatic cancer; EXPRESSION; RESISTANCE; PROTEIN; MACHINERY; CELL;
D O I：
10.1016/j.bbrc.2021.02.146
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Pancreatic cancer is a digestive tract malignancy characterized by an occult onset and rapid progression. The genetic heterogeneity of pancreatic cancer is closely related to its highly malignant biological behavior. The myelin and lymphocyte protein 2 (MAL2) is upregulated in multiple cancers at the transcriptional level. However, the exact role of MAL2 in pancreatic cancer remains elusive. In this study, we demonstrated that MAL2 protein and mRNA levels were upregulated in pancreatic cancer. MAL2 over expression was significantly associated with poor prognosis in patients with pancreatic cancer. We further showed that MAL2 interacted with IQGAP1 to increase ERK1/2 phosphorylation levels, which promoted pancreatic cancer progression. Therefore, these results suggest that MAL2 could be a novel therapeutic target for pancreatic cancer. ? 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码：63 / 70
页数：8
相关论文
共 50 条
  • [31] ASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer
    Xie, Wangkai
    Han, Zheng
    Zuo, Ziyi
    Xin, Dong
    Chen, Hua
    Huang, Juanjuan
    Zhu, Siyu
    Lou, Han
    Yu, Zhiqiang
    Chen, Chenbin
    Chen, Sian
    Hu, Yuanbo
    Huang, Jingjing
    Zhang, Fabiao
    Ni, Zhonglin
    Shen, Xian
    Xue, Xiangyang
    Lin, Kezhi
    CELL DEATH & DISEASE, 2023, 14 (02)
  • [32] Thymosinα1 stimulates cell proliferation by activating ERK1/2, JNK, and increasing cytokine secretion in human pancreatic cancer cells
    Li, Min
    Feurino, Louis W.
    Li, Fei
    Wang, Hao
    Zhai, Qihui
    Fisher, William E.
    Chen, Changyi
    Yao, Qizhi
    CANCER LETTERS, 2007, 248 (01) : 58 - 67
  • [33] ASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer
    Wangkai Xie
    Zheng Han
    Ziyi Zuo
    Dong Xin
    Hua Chen
    Juanjuan Huang
    Siyu Zhu
    Han Lou
    Zhiqiang Yu
    Chenbin Chen
    Sian Chen
    Yuanbo Hu
    Jingjing Huang
    Fabiao Zhang
    Zhonglin Ni
    Xian Shen
    Xiangyang Xue
    Kezhi Lin
    Cell Death & Disease, 14
  • [34] Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation
    Pitson, SM
    Moretti, PAB
    Zebol, JR
    Lynn, HE
    Xia, P
    Vadas, MA
    Wattenberg, BW
    EMBO JOURNAL, 2003, 22 (20): : 5491 - 5500
  • [35] Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells
    Carón, RW
    Yacoub, A
    Mitchell, C
    Zhu, XY
    Hong, Y
    Sasazuki, T
    Shirasawa, S
    Hagan, MP
    Grant, S
    Dent, P
    CELL CYCLE, 2005, 4 (03) : 456 - 464
  • [36] Relative levels of IQGAP1 and IQGAP2: Modulator of stemness, resistance and relapse dynamics in breast cancer
    Mohapatra, T.
    Dixit, M.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S145 - S145
  • [37] Ectopic overexpression of filamin C scaffolds MEK1/2 and ERK1/2 to promote the progression of human hepatocellular carcinoma
    Yang, Baicai
    Liu, Yun
    Zhao, Jie
    Hei, Kaiwen
    Zhuang, Hao
    Li, Qiang
    Wei, Wen
    Chen, Ruibing
    Zhang, Ning
    Li, Yongmei
    CANCER LETTERS, 2017, 388 : 167 - 176
  • [38] MAL2 expression predicts distant metastasis and short survival in pancreatic cancer
    Eguchi, Daiki
    Ohuchida, Kenoki
    Kozono, Shingo
    Ikenaga, Naoki
    Slaindo, Koji
    Cui, Lin
    Fujiwara, Kenji
    Akagawa, Shin
    Ohtsuka, Takao
    Takahata, Shunichi
    Tokunaga, Shoji
    Mizumoto, Kazuhiro
    Tanaka, Masao
    SURGERY, 2013, 154 (03) : 573 - 582
  • [39] Regulation of ERK1/2 Phosphorylation, Oxidation, and Cell Cycle Progression by Miro1 Mediated Mitochondrial Positioning
    Shannon, Nathaniel
    Raymond, Cory
    Seward, David
    Cunniff, Brian
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 224
  • [40] Decreased NSG3 enhances PD-L1 expression by Erk1/2 pathway to promote pancreatic cancer progress
    Xia, Xigang
    Li, Ran
    Zhou, Peng
    Xing, Zhixiang
    Lu, Chao
    Long, Zhida
    Wang, Feiyang
    Wang, Rui
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (03): : 916 - +
12345